Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial
Go back to Bluejay Diagnostics, Inc. Announces Completion of 624 Patient Enrollments in SYMON-II Pivotal Clinical Trial| (NASDAQ: BJDX) | Delayed: 3.88 +0.02 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.86 | 52 Week High | $ | |||
| Open | $3.88 | 52 Week Low | $ | |||
| Day High | $4.05 | P/E | N/A | |||
| Day Low | $3.81 | EPS | $ | |||
| Volume | 39,934 | |||||
